VWF and acute coronary syndrome: Similar to previous studies where we investigated ex vivo effects of BT200 in healthy volunteers after stimulated VWF release with endotoxin or desmopressin38 and in acute coronary syndrome (ACS) patients53, we have again shown that higher concentrations of BT200 were needed for the same effect in cases of increased VWF when compared to normal VWF levels.